Loading…

Comprehensive Analysis of Key mRNAs and lncRNAs in Osteosarcoma Response to Preoperative Chemotherapy with Prognostic Values

Objective Osteosarcoma is one of the most common types of bone sarcoma with a poor prognosis. However, identifying the predictive factors that contribute to the response to neoadjuvant chemotherapy remains a significant challenge. Methods A public data series (GSE87437) was downloaded to identify di...

Full description

Saved in:
Bibliographic Details
Published in:Current medical science 2021-10, Vol.41 (5), p.916-929
Main Authors: Li, Mi, Cheng, Wei-ting, Li, Hao, Zhang, Zhi, Lu, Xiao-li, Deng, Si-si, Li, Jian, Yang, Cai-hong
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c332t-102366bb668c3f3f0a8e55f316a2a2c9c6b362c67c6bbc0db66be7cabd4014383
container_end_page 929
container_issue 5
container_start_page 916
container_title Current medical science
container_volume 41
creator Li, Mi
Cheng, Wei-ting
Li, Hao
Zhang, Zhi
Lu, Xiao-li
Deng, Si-si
Li, Jian
Yang, Cai-hong
description Objective Osteosarcoma is one of the most common types of bone sarcoma with a poor prognosis. However, identifying the predictive factors that contribute to the response to neoadjuvant chemotherapy remains a significant challenge. Methods A public data series (GSE87437) was downloaded to identify differentially expressed genes (DEGs) and differentially expressed lncRNAs (DElncRNAs) between osteosarcoma patients that do and do not respond to preoperative chemotherapy. Subsequently, functional analysis of the transcriptome expression profile, regulatory networks of DEGs and DElncRNAs, competing endogenous RNAs (ceRNA) and protein-protein interaction networks were performed. Furthermore, the function, pathway, and survival analysis of hub genes was performed and drug and disease relationship prediction of DElncRNA was carried out. Results A total of 626 DEGs, 26 DElncRNAs, and 18 hub genes were identified. However, only one gene and two lncRNAs were found to be suitable as candidate gene and lncRNAs respectively. Conclusion The DEGs, hub genes, candidate gene, and candidate lncRNAs screened out in this context were considered as potential biomarkers for the response to neoadjuvant chemotherapy of osteosarcoma.
doi_str_mv 10.1007/s11596-021-2430-2
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2585462093</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2585462093</sourcerecordid><originalsourceid>FETCH-LOGICAL-c332t-102366bb668c3f3f0a8e55f316a2a2c9c6b362c67c6bbc0db66be7cabd4014383</originalsourceid><addsrcrecordid>eNp9kEtPwzAQhC0EgqrwA7ggH7kE_Ejc5FhVvASiqALEzXLcDQ1K7OBNQZX48bi0cOS0s5rZWekj5JizM87Y6Bw5zwqVMMETkUqWiB0yEJmQSV4UL7tRs-jGnR2QI8S6ZJILJXku9smBTNWIFywdkK-Jb7sAC3BYfwAdO9OssEbqK3oLK9rO7sdIjZvTxtkfXTs6xR48mmB9a-gMsPMOgfaePgTwHQTTr6smC2h9v4hrt6Kfdb-Itn91Hvva0mfTLAEPyV5lGoSj7RySp8uLx8l1cje9upmM7xIrpegTzoRUqiyVyq2sZMVMDllWSa6MMMIWVpVSCatGUZSWzWOwhJE15TxlPJW5HJLTTW8X_Hv82-u2RgtNYxz4JWqR5VmqIjAZo3wTtcEjBqh0F-rWhJXmTK-56w13HbnrNXct4s3Jtn5ZtjD_u_ilHANiE8BouVcI-s0vQ0SN_7R-A6X7j2I</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2585462093</pqid></control><display><type>article</type><title>Comprehensive Analysis of Key mRNAs and lncRNAs in Osteosarcoma Response to Preoperative Chemotherapy with Prognostic Values</title><source>Springer Nature</source><creator>Li, Mi ; Cheng, Wei-ting ; Li, Hao ; Zhang, Zhi ; Lu, Xiao-li ; Deng, Si-si ; Li, Jian ; Yang, Cai-hong</creator><creatorcontrib>Li, Mi ; Cheng, Wei-ting ; Li, Hao ; Zhang, Zhi ; Lu, Xiao-li ; Deng, Si-si ; Li, Jian ; Yang, Cai-hong</creatorcontrib><description>Objective Osteosarcoma is one of the most common types of bone sarcoma with a poor prognosis. However, identifying the predictive factors that contribute to the response to neoadjuvant chemotherapy remains a significant challenge. Methods A public data series (GSE87437) was downloaded to identify differentially expressed genes (DEGs) and differentially expressed lncRNAs (DElncRNAs) between osteosarcoma patients that do and do not respond to preoperative chemotherapy. Subsequently, functional analysis of the transcriptome expression profile, regulatory networks of DEGs and DElncRNAs, competing endogenous RNAs (ceRNA) and protein-protein interaction networks were performed. Furthermore, the function, pathway, and survival analysis of hub genes was performed and drug and disease relationship prediction of DElncRNA was carried out. Results A total of 626 DEGs, 26 DElncRNAs, and 18 hub genes were identified. However, only one gene and two lncRNAs were found to be suitable as candidate gene and lncRNAs respectively. Conclusion The DEGs, hub genes, candidate gene, and candidate lncRNAs screened out in this context were considered as potential biomarkers for the response to neoadjuvant chemotherapy of osteosarcoma.</description><identifier>ISSN: 2096-5230</identifier><identifier>EISSN: 2523-899X</identifier><identifier>DOI: 10.1007/s11596-021-2430-2</identifier><identifier>PMID: 34671904</identifier><language>eng</language><publisher>Wuhan: Huazhong University of Science and Technology</publisher><subject>Biomarkers, Tumor - genetics ; Bone Neoplasms - drug therapy ; Bone Neoplasms - genetics ; Bone Neoplasms - surgery ; Computational Biology - methods ; Databases, Genetic ; Gene Expression Profiling ; Gene Expression Regulation, Neoplastic ; Gene Regulatory Networks ; Humans ; Medicine ; Medicine &amp; Public Health ; Neoadjuvant Therapy ; Osteosarcoma - drug therapy ; Osteosarcoma - genetics ; Osteosarcoma - surgery ; Prognosis ; RNA, Long Noncoding - genetics ; Survival Analysis</subject><ispartof>Current medical science, 2021-10, Vol.41 (5), p.916-929</ispartof><rights>Huazhong University of Science and Technology 2021</rights><rights>2021. Huazhong University of Science and Technology.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c332t-102366bb668c3f3f0a8e55f316a2a2c9c6b362c67c6bbc0db66be7cabd4014383</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34671904$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Li, Mi</creatorcontrib><creatorcontrib>Cheng, Wei-ting</creatorcontrib><creatorcontrib>Li, Hao</creatorcontrib><creatorcontrib>Zhang, Zhi</creatorcontrib><creatorcontrib>Lu, Xiao-li</creatorcontrib><creatorcontrib>Deng, Si-si</creatorcontrib><creatorcontrib>Li, Jian</creatorcontrib><creatorcontrib>Yang, Cai-hong</creatorcontrib><title>Comprehensive Analysis of Key mRNAs and lncRNAs in Osteosarcoma Response to Preoperative Chemotherapy with Prognostic Values</title><title>Current medical science</title><addtitle>CURR MED SCI</addtitle><addtitle>Curr Med Sci</addtitle><description>Objective Osteosarcoma is one of the most common types of bone sarcoma with a poor prognosis. However, identifying the predictive factors that contribute to the response to neoadjuvant chemotherapy remains a significant challenge. Methods A public data series (GSE87437) was downloaded to identify differentially expressed genes (DEGs) and differentially expressed lncRNAs (DElncRNAs) between osteosarcoma patients that do and do not respond to preoperative chemotherapy. Subsequently, functional analysis of the transcriptome expression profile, regulatory networks of DEGs and DElncRNAs, competing endogenous RNAs (ceRNA) and protein-protein interaction networks were performed. Furthermore, the function, pathway, and survival analysis of hub genes was performed and drug and disease relationship prediction of DElncRNA was carried out. Results A total of 626 DEGs, 26 DElncRNAs, and 18 hub genes were identified. However, only one gene and two lncRNAs were found to be suitable as candidate gene and lncRNAs respectively. Conclusion The DEGs, hub genes, candidate gene, and candidate lncRNAs screened out in this context were considered as potential biomarkers for the response to neoadjuvant chemotherapy of osteosarcoma.</description><subject>Biomarkers, Tumor - genetics</subject><subject>Bone Neoplasms - drug therapy</subject><subject>Bone Neoplasms - genetics</subject><subject>Bone Neoplasms - surgery</subject><subject>Computational Biology - methods</subject><subject>Databases, Genetic</subject><subject>Gene Expression Profiling</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>Gene Regulatory Networks</subject><subject>Humans</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Neoadjuvant Therapy</subject><subject>Osteosarcoma - drug therapy</subject><subject>Osteosarcoma - genetics</subject><subject>Osteosarcoma - surgery</subject><subject>Prognosis</subject><subject>RNA, Long Noncoding - genetics</subject><subject>Survival Analysis</subject><issn>2096-5230</issn><issn>2523-899X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kEtPwzAQhC0EgqrwA7ggH7kE_Ejc5FhVvASiqALEzXLcDQ1K7OBNQZX48bi0cOS0s5rZWekj5JizM87Y6Bw5zwqVMMETkUqWiB0yEJmQSV4UL7tRs-jGnR2QI8S6ZJILJXku9smBTNWIFywdkK-Jb7sAC3BYfwAdO9OssEbqK3oLK9rO7sdIjZvTxtkfXTs6xR48mmB9a-gMsPMOgfaePgTwHQTTr6smC2h9v4hrt6Kfdb-Itn91Hvva0mfTLAEPyV5lGoSj7RySp8uLx8l1cje9upmM7xIrpegTzoRUqiyVyq2sZMVMDllWSa6MMMIWVpVSCatGUZSWzWOwhJE15TxlPJW5HJLTTW8X_Hv82-u2RgtNYxz4JWqR5VmqIjAZo3wTtcEjBqh0F-rWhJXmTK-56w13HbnrNXct4s3Jtn5ZtjD_u_ilHANiE8BouVcI-s0vQ0SN_7R-A6X7j2I</recordid><startdate>20211001</startdate><enddate>20211001</enddate><creator>Li, Mi</creator><creator>Cheng, Wei-ting</creator><creator>Li, Hao</creator><creator>Zhang, Zhi</creator><creator>Lu, Xiao-li</creator><creator>Deng, Si-si</creator><creator>Li, Jian</creator><creator>Yang, Cai-hong</creator><general>Huazhong University of Science and Technology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20211001</creationdate><title>Comprehensive Analysis of Key mRNAs and lncRNAs in Osteosarcoma Response to Preoperative Chemotherapy with Prognostic Values</title><author>Li, Mi ; Cheng, Wei-ting ; Li, Hao ; Zhang, Zhi ; Lu, Xiao-li ; Deng, Si-si ; Li, Jian ; Yang, Cai-hong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c332t-102366bb668c3f3f0a8e55f316a2a2c9c6b362c67c6bbc0db66be7cabd4014383</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Biomarkers, Tumor - genetics</topic><topic>Bone Neoplasms - drug therapy</topic><topic>Bone Neoplasms - genetics</topic><topic>Bone Neoplasms - surgery</topic><topic>Computational Biology - methods</topic><topic>Databases, Genetic</topic><topic>Gene Expression Profiling</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>Gene Regulatory Networks</topic><topic>Humans</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Neoadjuvant Therapy</topic><topic>Osteosarcoma - drug therapy</topic><topic>Osteosarcoma - genetics</topic><topic>Osteosarcoma - surgery</topic><topic>Prognosis</topic><topic>RNA, Long Noncoding - genetics</topic><topic>Survival Analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Li, Mi</creatorcontrib><creatorcontrib>Cheng, Wei-ting</creatorcontrib><creatorcontrib>Li, Hao</creatorcontrib><creatorcontrib>Zhang, Zhi</creatorcontrib><creatorcontrib>Lu, Xiao-li</creatorcontrib><creatorcontrib>Deng, Si-si</creatorcontrib><creatorcontrib>Li, Jian</creatorcontrib><creatorcontrib>Yang, Cai-hong</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Current medical science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Li, Mi</au><au>Cheng, Wei-ting</au><au>Li, Hao</au><au>Zhang, Zhi</au><au>Lu, Xiao-li</au><au>Deng, Si-si</au><au>Li, Jian</au><au>Yang, Cai-hong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comprehensive Analysis of Key mRNAs and lncRNAs in Osteosarcoma Response to Preoperative Chemotherapy with Prognostic Values</atitle><jtitle>Current medical science</jtitle><stitle>CURR MED SCI</stitle><addtitle>Curr Med Sci</addtitle><date>2021-10-01</date><risdate>2021</risdate><volume>41</volume><issue>5</issue><spage>916</spage><epage>929</epage><pages>916-929</pages><issn>2096-5230</issn><eissn>2523-899X</eissn><abstract>Objective Osteosarcoma is one of the most common types of bone sarcoma with a poor prognosis. However, identifying the predictive factors that contribute to the response to neoadjuvant chemotherapy remains a significant challenge. Methods A public data series (GSE87437) was downloaded to identify differentially expressed genes (DEGs) and differentially expressed lncRNAs (DElncRNAs) between osteosarcoma patients that do and do not respond to preoperative chemotherapy. Subsequently, functional analysis of the transcriptome expression profile, regulatory networks of DEGs and DElncRNAs, competing endogenous RNAs (ceRNA) and protein-protein interaction networks were performed. Furthermore, the function, pathway, and survival analysis of hub genes was performed and drug and disease relationship prediction of DElncRNA was carried out. Results A total of 626 DEGs, 26 DElncRNAs, and 18 hub genes were identified. However, only one gene and two lncRNAs were found to be suitable as candidate gene and lncRNAs respectively. Conclusion The DEGs, hub genes, candidate gene, and candidate lncRNAs screened out in this context were considered as potential biomarkers for the response to neoadjuvant chemotherapy of osteosarcoma.</abstract><cop>Wuhan</cop><pub>Huazhong University of Science and Technology</pub><pmid>34671904</pmid><doi>10.1007/s11596-021-2430-2</doi><tpages>14</tpages></addata></record>
fulltext fulltext
identifier ISSN: 2096-5230
ispartof Current medical science, 2021-10, Vol.41 (5), p.916-929
issn 2096-5230
2523-899X
language eng
recordid cdi_proquest_miscellaneous_2585462093
source Springer Nature
subjects Biomarkers, Tumor - genetics
Bone Neoplasms - drug therapy
Bone Neoplasms - genetics
Bone Neoplasms - surgery
Computational Biology - methods
Databases, Genetic
Gene Expression Profiling
Gene Expression Regulation, Neoplastic
Gene Regulatory Networks
Humans
Medicine
Medicine & Public Health
Neoadjuvant Therapy
Osteosarcoma - drug therapy
Osteosarcoma - genetics
Osteosarcoma - surgery
Prognosis
RNA, Long Noncoding - genetics
Survival Analysis
title Comprehensive Analysis of Key mRNAs and lncRNAs in Osteosarcoma Response to Preoperative Chemotherapy with Prognostic Values
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T14%3A34%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comprehensive%20Analysis%20of%20Key%20mRNAs%20and%20lncRNAs%20in%20Osteosarcoma%20Response%20to%20Preoperative%20Chemotherapy%20with%20Prognostic%20Values&rft.jtitle=Current%20medical%20science&rft.au=Li,%20Mi&rft.date=2021-10-01&rft.volume=41&rft.issue=5&rft.spage=916&rft.epage=929&rft.pages=916-929&rft.issn=2096-5230&rft.eissn=2523-899X&rft_id=info:doi/10.1007/s11596-021-2430-2&rft_dat=%3Cproquest_cross%3E2585462093%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c332t-102366bb668c3f3f0a8e55f316a2a2c9c6b362c67c6bbc0db66be7cabd4014383%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2585462093&rft_id=info:pmid/34671904&rfr_iscdi=true